Results 181 to 190 of about 414,407 (362)

Biphasic Glucocorticoid Rhythm in One-Month-Old Infants: Reflection of a Developing HPA-Axis? [PDF]

, 2019
Jonneke J. Hollanders, Bibian van der Voorn, Paul de Goede, Alyssa A Toorop, Lisette R. Dijkstra, Adriaan Honig, Joost Rotteveel, Koert M. Dolman, Andries Kalsbeek, Martijn J.J. Finken   +9 more
openalex   +1 more source

Glucocorticoid antagonists

FEBS Letters, 1987
Agarwal, M.K., Hainque, B., Moustaid, N., Lazer, G.   +3 more
openaire   +2 more sources

Engineering Immune Cell to Counteract Aging and Aging‐Associated Diseases

Advanced Science, EarlyView.
This review highlights a paradigm shift in which advanced immune cell therapies, initially developed for cancer, are now being harnessed to combat aging. By engineering immune cells to selectively clear senescent cells and remodel pro‐inflammatory tissue microenvironments, these strategies offer a novel and powerful approach to delay age‐related ...
Jianhua Guo, Lanjie Lei, Ying Jin, Lan Su, Shumao Cui, Liyun Shi   +5 more
wiley   +1 more source

NHẬN XÉT TÌNH TRẠNG TĂNG ĐƯỜNG HUYẾT SAU LIỆU PHÁP GLUCOCORTICOID Ở THAI PHỤ BỊ ĐÁI THÁO ĐƯỜNG THAI KỲ

, 2023
Duy Hưng Trịnh, Thị Kim Chung Nguyễn, Đức Lam Nguyễn, Thị Thanh Nguyễn   +3 more
openalex   +2 more sources

Self‐Assembled Myricetin‐Arginine Conjugate Nanozymes for Targeted Suppression of Joint Inflammation and Osteoclastogenesis in Rheumatoid Arthritis

Advanced Science, EarlyView.
Carrier‐free myricetin‐arginine conjugate nanozymes (MANZs) have been fabricated through a Mannich reaction and spontaneous self‐assembly. MANZs selectively accumulate in inflamed joints by targeting M1 macrophages via CAT2‐mediated uptake. The nanozymes can effectively modulate macrophage polarization, suppress osteoclast differentiation, and mitigate
Jiachang Hong, Penghao Ji, Jinxi An, Junchao Huang, Ziheng Bu, Xudong Zhang, Wei Liu, Tingyu Wu, Sen Wang, Wei Zhu, Yuhui Li, Jixian Wan, Sudan Xu, Minfeng Huo, Peng Wu   +14 more
wiley   +1 more source

Unmasking Isolated Glucocorticoid Deficiency: Clinical Insights From 2 Cases. [PDF]

JCEM Case Rep
Singhal A, Menon JC, Yadav SC, Gupta A, Sriharsha G, Bhatia E.   +5 more
europepmc   +1 more source

PF451 GLUCOCORTICOID INDUCED LEUCINE ZIPPER (GILZ) IS REQUIRED FOR HEMATOPOIETIC STEM CELL FUNCTION

, 2019
Oxana Bereshchenko, Stefano Bruscoli, Tiziana Frammartino, Sara Flamini, Andrea Gagliardi, Zenobio Viana de Barros, Carlo Riccardi   +6 more
openalex   +1 more source

Identification of Compound Heterozygous CYP11A1 Variants via Reanalysis of Clinical Sequencing Data

American Journal of Medical Genetics Part A, EarlyView.
ABSTRACT A molecular diagnosis is currently achievable in approximately 50% of patients assessed by clinical geneticists at tertiary care centres. Next‐Generation Sequencing Panels contain a defined group of genes associated with a clinically defined set of phenotypes.
Ana Acosta Bedón, Vahid Akbari, Ralph Rothstein, Alexandra Inman, Sanjiv Bhalla, Jianghong An, Jan M. Friedman, Rosanna Weksberg, Cornelius Boerkoel, Steven J. M. Jones, William T. Gibson   +10 more
wiley   +1 more source

Platelet-to-neutrophil ratio and in-hospital mortality in pneumonia patients receiving glucocorticoid therapy: a multicenter retrospective cohort study. [PDF]

Front Med (Lausanne)
Lin J, Chen R, Xu S, Lin W.
europepmc   +1 more source

Variants in AKR1D1 and Infant Mortality: Should Bile Acid Screening be a Routine Part of Newborn Screening?

American Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Biallelic pathogenic variants in AKR1D1 cause Δ4‐3‐oxosteroid 5β‐reductase deficiency, disrupt bile acid synthesis, and result in Congenital Bile Acid Synthesis defect type 2 (CBAS2). CBAS2 presents in infancy with cholestasis, coagulopathy, and failure to thrive.
Jade Hudson, Stephanie Hyunh, Bojana Rakic, Cornelius Boerkoel   +3 more
wiley   +1 more source